Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants
- PMID: 18410100
- PMCID: PMC2610460
- DOI: 10.1021/ja801008m
Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants
Abstract
QS-7-Api is an exceedingly potent immuno-adjuvant isolated from the bark of Quillaja saponaria. It is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccine clinical trials. Tedious isolation/purification protocols and uncertainty in its structural constitution have hindered the clinical development of QS-7. A chemical synthesis of QS-7-Api is described, providing structural verification of the adjuvant. A novel semisynthetic sequence to QS-7-Api has also been established, greatly facilitating access to QS-7 for preclinical and clinical evaluation.
Figures




Similar articles
-
Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi.J Am Chem Soc. 2006 Sep 13;128(36):11906-15. doi: 10.1021/ja062364i. J Am Chem Soc. 2006. PMID: 16953631 Free PMC article.
-
Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21.Methods Mol Biol. 2017;1494:45-71. doi: 10.1007/978-1-4939-6445-1_4. Methods Mol Biol. 2017. PMID: 27718185 Free PMC article.
-
Synthesis of the potent immunostimulatory adjuvant QS-21A.J Am Chem Soc. 2005 Mar 16;127(10):3256-7. doi: 10.1021/ja0422007. J Am Chem Soc. 2005. PMID: 15755124
-
Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.Expert Rev Vaccines. 2011 Apr;10(4):463-70. doi: 10.1586/erv.11.18. Expert Rev Vaccines. 2011. PMID: 21506644 Free PMC article. Review.
-
Foamy matters: an update on Quillaja saponins and their use as immunoadjuvants.Future Med Chem. 2019 Jun;11(12):1485-1499. doi: 10.4155/fmc-2018-0438. Epub 2019 Jul 15. Future Med Chem. 2019. PMID: 31304830 Review.
Cited by
-
Synthesis of the hexacyclic triterpene core of the jujuboside saponins via tandem Wolff rearrangement-intramolecular ketene hetero-Diels-Alder reaction.Tetrahedron. 2018 Jun 28;74(26):3370-3383. doi: 10.1016/j.tet.2018.04.051. Epub 2018 Apr 19. Tetrahedron. 2018. PMID: 30467444 Free PMC article.
-
Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant.Curr Drug ther. 2011 Aug;6(3):207-212. doi: 10.2174/157488511796391988. Curr Drug ther. 2011. PMID: 25473385 Free PMC article.
-
Recent progress in chemical and chemoenzymatic synthesis of carbohydrates.Curr Opin Chem Biol. 2009 Dec;13(5-6):573-81. doi: 10.1016/j.cbpa.2009.09.013. Epub 2009 Oct 14. Curr Opin Chem Biol. 2009. PMID: 19833544 Free PMC article. Review.
-
Immunological and Toxicological Assessment of Triterpenoid Saponins Bearing Lewis-X- and QS-21-Based Trisaccharides.Chemistry. 2025 May 19;31(28):e202500994. doi: 10.1002/chem.202500994. Epub 2025 Apr 21. Chemistry. 2025. PMID: 40192644 Free PMC article.
-
Direct Dehydrative Glycosylation of C1-Alcohols.Chem Asian J. 2018 Oct 18;13(20):2978-2990. doi: 10.1002/asia.201800971. Epub 2018 Oct 1. Chem Asian J. 2018. PMID: 30019854 Free PMC article. Review.
References
-
- Kensil CR, Patel U, Lennick M, Marciani D. J Immunol. 1991;146:431–437. - PubMed
-
- Soltysik S, Wu JY, Recchia J, Wheeler DA, Newman MJ, Coughlin RT, Kensil CR. Vaccine. 1995;13:1403–1410. - PubMed
-
- Kensil CR. Crit Rev Ther Drug Carrier Syst. 1996;13:1–55. - PubMed
-
- Kim SK, Ragupathi G, Musselli C, Choi SJ, Park YS, Livingston PO. Vaccine. 2000;18:597–603. - PubMed
-
- Livingston PO, Ragupathi G. Hum Vaccines. 2006;2:137–143. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources